Tenax Therapeutics, Inc. (TENX)
1.51
-0.02
(-1.63%)
USD |
NASDAQ |
Oct 15, 16:00
1.515
0.00 (0.00%)
After-Hours: 20:00
Tenax Therapeutics Cash from Operations (TTM) : -46.03M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -46.03M |
| March 31, 2026 | -38.14M |
| December 31, 2025 | -35.80M |
| September 30, 2025 | -25.91M |
| June 30, 2025 | -19.84M |
| March 31, 2025 | -16.61M |
| December 31, 2024 | -14.81M |
| September 30, 2024 | -12.46M |
| June 30, 2024 | -11.45M |
| March 31, 2024 | -9.344M |
| December 31, 2023 | -5.904M |
| September 30, 2023 | -7.042M |
| June 30, 2023 | -8.292M |
| March 31, 2023 | -10.80M |
| December 31, 2022 | -12.01M |
| September 30, 2022 | -12.47M |
| June 30, 2022 | -12.16M |
| March 31, 2022 | -10.57M |
| December 31, 2021 | -10.86M |
| September 30, 2021 | -10.08M |
| June 30, 2021 | -9.439M |
| March 31, 2021 | -9.823M |
| December 31, 2020 | -9.273M |
| September 30, 2020 | -9.012M |
| June 30, 2020 | -8.409M |
| Date | Value |
|---|---|
| March 31, 2020 | -8.094M |
| December 31, 2019 | -7.556M |
| September 30, 2019 | -7.028M |
| June 30, 2019 | -6.801M |
| March 31, 2019 | -6.074M |
| December 31, 2018 | -5.500M |
| September 30, 2018 | -5.584M |
| June 30, 2018 | -5.254M |
| March 31, 2018 | -9.662M |
| December 31, 2017 | -12.14M |
| September 30, 2017 | -13.96M |
| June 30, 2017 | -17.02M |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| April 30, 2016 | |
| January 31, 2016 | |
| October 31, 2015 | |
| July 31, 2015 | -11.61M |
| April 30, 2015 | -9.749M |
| January 31, 2015 | -11.10M |
| October 31, 2014 | -10.58M |
| July 31, 2014 | -9.681M |
| April 30, 2014 | -9.262M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Exicure, Inc. | -6.704M |
| Century Therapeutics, Inc. | -86.74M |
| Absci Corp. | -108.08M |
| Celularity, Inc. | -8.814M |
| Cardio Diagnostics Holdings, Inc. | -5.660M |